Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

236 ARTÍCULOS , VIENDO DEL 106 AL 120

Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years

Darmanthé N, Tabatabaei-Jafari H, Cherbuin N; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2021;82(3):951-964. doi: 10.3233/JAD-210092.

The Influence of Serum Uric Acid Level on Alzheimer's Disease: A Narrative Review

Qiao M, Chen C, Liang Y, Luo Y, Wu W.

Biomed Res Int. 2021 Jun 2;2021:5525710. doi: 10.1155/2021/5525710. eCollection 2021.

Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease

Byeon SK, Madugundu AK, Jain AP, Bhat FA, Jung JH, Renuse S, Darrow J, Bakker A, Albert M, Moghekar A, Pandey A.

Mol Omics. 2021 Jun 14;17(3):454-463. doi: 10.1039/d0mo00186d.

Anosognosia in dementia with Lewy bodies: a systematic review

Calil V, Sudo FK, Santiago-Bravo G, Lima MA, Mattos P.

Arq Neuropsiquiatr. 2021 Apr;79(4):334-342. doi: 10.1590/0004-282X-ANP-2020-0247.

Contribution of Gut Microbiota to Immunological Changes in Alzheimer's Disease

van Olst L, Roks SJM, Kamermans A, Verhaar BJH, van der Geest AM, Muller M, van der Flier WM, de Vries HE.

Front Immunol. 2021 May 31;12:683068. doi: 10.3389/fimmu.2021.683068. eCollection 2021.

Plasma Levels of Amyloid-β Peptides and Tau Protein in Mexican Patients with Alzheimer's Disease

Castillo-Mendieta T, Arana-Lechuga Y, Campos-Peña V, Sosa AL, Orozco-Suarez S, Pinto-Almazán R, Segura-Uribe J, Javier Rodríguez-Sánchez de Tagle A, Ruiz-Sánchez E, Guerra-Araiza C.

J Alzheimers Dis. 2021;82(s1):S271-S281. doi: 10.3233/JAD-200912.

Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study

Wang ZT, Li KY, Tan CC, Xu W, Shen XN, Cao XP, Wang P, Bi YL, Dong Q, Tan L, Yu JT.

J Alzheimers Dis. 2021;82(3):1045-1054. doi: 10.3233/JAD-210140.

The Associations of Plasma/Serum Carotenoids with Alzheimer's Disease: A Systematic Review and Meta-Analysis

Qu M, Shi H, Wang K, Wang X, Yu N, Guo B.

J Alzheimers Dis. 2021;82(3):1055-1066. doi: 10.3233/JAD-210384.

Decreased Levels of Insulin-Like Growth Factor-1 Are Associated with Alzheimer's Disease: A Meta-Analysis

Xu LZ, Li FY, Li BQ, Cao SM, Li Y, Xu J, Jia JP.

J Alzheimers Dis. 2021;82(3):1357-1367. doi: 10.3233/JAD-210516.

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease

Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, Cruchaga C, Goate AA, Perrin RJ, Xiong C, Li Y, Morris JC, Snider BJ, Mummery C, Surti GM, Hannequin D, Wallon D, Berman SB, Lah JJ, Jimenez-Velazquez IZ, Roberson ED, van Dyck CH, Honig LS, Sánchez-Valle R, Brooks WS, Gauthier S, Galasko DR, Masters CL, Brosch JR, Hsiung GR, Jayadev S, Formaglio M, Masellis M, Clarnette R, Pariente J, Dubois B, Pasquier F, Jack CR Jr, Koeppe R, Snyder PJ, Aisen PS, Thomas RG, Berry SM, Wendelberger BA, Andersen SW, Holdridge KC, Mintun MA, Yaari R, Sims JR, Baudler M, Delmar P, Doody RS, Fontoura P, Giacobino C, Kerchner GA, Bateman RJ; Dominantly Inherited Alzheimer Network–Trials Unit.

Nat Med. 2021 Jul;27(7):1187-1196. doi: 10.1038/s41591-021-01369-8. Epub 2021 Jun 21.

Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease

Athar T, Al Balushi K, Khan SA.

Mol Biol Rep. 2021 Jul;48(7):5629-5645. doi: 10.1007/s11033-021-06512-9. Epub 2021 Jun 28.

New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids

Gallo A, Pillet LE, Verpillot R.

Exp Gerontol. 2021 Sep;152:111452. doi: 10.1016/j.exger.2021.111452. Epub 2021 Jun 26.

Cellular Senescence and ApoE4: Their Repercussions in Alzheimer's Disease

Tecalco-Cruz AC, Zepeda-Cervantes J, López-Canovas L, Ramírez-Jarquín JO, Pedraza-Chaverrí J, Briones-Herrera A.

CNS Neurol Disord Drug Targets. 2021;20(9):778-785. doi: 10.2174/1871527320666210628102721.

Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease

Balendra V, Singh SK.

Open Biol. 2021 Jun;11(6):210013. doi: 10.1098/rsob.210013. Epub 2021 Jun 30.

What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?

Gaunitz S, Tjernberg LO, Schedin-Weiss S.

Biomolecules. 2021 Jun 9;11(6):858. doi: 10.3390/biom11060858.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias